Quality of life of patients with telemetric pumps for intrathecal baclofen infusion: data and limitations of assessment scales.
Over the past three decades, telemetric pumps have been used for the infusion of intrathecal baclofen in patients with severe spasticity, but the correlation between pump implantation and quality of life (QoL) has rarely been studied. The aim of this study was therefore to quantify QoL in these patients. We assessed 15 candidates for intrathecal baclofen infusion pump implantation using three scales: Self-Evaluation of Life Function, Quality of Life Index, and Quality of Well-Being Scale. These scales were administered a week before pump implantation and 12 months after reaching the optimal dosage. The first scale revealed a significant increase in QoL, whereas on the other two the increase was not significant. These results encourage us to continue this study in a larger patient sample, considering different types of pathology and presence/absence of caregivers.
Bramanti
Placido
P
Centro Studi Neurolesi, University of Messina, Italy.
D'Aleo
Giangaetano
G
Rifici
Carmela
C
Alagna
Antonella
A
Cannata
Angelo
A
Sessa
Edoardo
E
Di Bella
Paolo
P
Marra
Giuseppe
G
D000328:Adult; D000368:Aged; D001418:Baclofen / Q000008:administration & dosage* / Q000627:therapeutic use; D002908:Chronic Disease; D004185:Disability Evaluation; D005260:Female; D006801:Humans; D015918:Infusion Pumps, Implantable; D007278:Injections, Spinal; D008297:Male; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000008:administration & dosage* / Q000627:therapeutic use; D009128:Muscle Spasticity / Q000188:drug therapy* / Q000503:physiopathology* / Q000523:psychology; D011788:Quality of Life; D011795:Surveys and Questionnaires; D013686:Telemetry
D009125:Muscle Relaxants, Central; D001418:Baclofen